Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: Confirmation of samples screened by immunoassay

Annals of Clinical Biochemistry

Volumn 47, Issue 2, 2010, Pages 111-117

  Glover, Sarah J ^a   Allen, Keith R ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYETHYLFLURAZEPAM; 7 AMINO 1,3 DIHYDRO 5 PHENYL 2H 1,4 BENZODIAZEPIN 2 ONE; 7 AMINOCLONAZEPAM; 7 AMINOFLUNITRAZEPAM; ALPHA HYDROXYALPRAZOLAM; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; LORAZEPAM; LORMETAZEPAM; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; TEMAZEPAM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SCREENING; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; URINALYSIS;

BENZODIAZEPINES; BIOLOGICAL ASSAY; CALIBRATION; CHROMATOGRAPHY, LIQUID; EUROPEAN UNION; IMMUNOASSAY; LIMIT OF DETECTION; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TEMAZEPAM;

EID: 77749292327     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009172     Document Type: Article

References (30)

1. Dixon R. Radioimmunoassay of benzodiazepines. Methods Enzymol 1982;84:490-515
2. Borggaard B, Joergensen I. Urinary screening for benzodiazepines with radioreceptor assay: comparison with EMIT d.a.u. benzodiazepine assay and high-performance liquid chromatography. J Anal Toxicol 1994;18:243-6
3. Becker J, Correll A, Koepf W, Rittner C. Comparative studies on the detection of benzodiazepines in serum by means of immunoassays (FPIA). J Anal Toxicol 1993;17:103-8
4. Beck O, Lin Z, Brodin K, Borg S, Hjemdahl P. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS. J Anal Toxicol 1997;21:554-7
5. Fitzgerald RL, Rexin DA, Herold DA. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry. Clin Chem 1994;40:373-80
6. Borrey D, Meyer E, Duchateau L, Lambert W, Van PC, De Leenheer AP. Longitudinal study on the prevalence of benzodiazepine (mis)use in a prison: importance of the analytical strategy. Addiction 2003;98:1427-32
7. Society of Forensic Toxicologists Inc. and American Academy of Forensic Sciences. Forensic Toxicology Laboratory Guidelines. 2006
8. ElSohly MA, Gul W, Avula B, Murphy TP, Khan IA. Simultaneous analysis of thirty-five benzodiazepines in urine using liquid chromatography-mass spectrometry-time of flight. J Anal Toxicol 2008;32:547-61
9. Quintela O, Sauvage FL, Charvier F, Gaulier JM, Lachatre G, Marquet P. Liquid chromatography-tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine: method with forensic applications. Clin Chem 2006;52:1346-55
10. Marin SJ, Coles R, Merrell M, McMillin GA. Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS. J Anal Toxicol 2008;32:491-8
11. Smink BE, Mathijssen MP, Lusthof KJ, de Gier JJ, Egberts AC, Uges DR. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS). J Anal Toxicol 2006;30:478-85
12. Zweigenbaum J, Heinig K, Steinborner S, Wachs T, Henion J. High-throughput bioanalytical LC/MS/MS determination of benzodiazepines in human urine: 1000 samples per 12 hours. Anal Chem 1999;71:2294-300
13. European Union Decision 2002/657/EC 17.08.2002. Off J Eur Commun 2002;221:8-36
14. Annesley TM. Ion suppression in mass spectrometry. Clin Chem 2003;49:1041-4
15. Lambert WE, Meyer E, Xue-Ping Y, De Leenheer AP. Screening, identification, and quantitation of benzodiazepines in postmortem samples by HPLC with photodiode array detection. J Anal Toxicol 1995;19:35-40
16. Borrey D, Meyer E, Lambert W, Van PC, De Leenheer AP. Simultaneous determination of fifteen low-dosed benzodiazepines in human urine by solid-phase extraction and gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 2001; Elsevier, Amsterdam, 765:187-97
17. Kraemer T, Maurer H. Therapeutic drugs: sedatives and hypnotics. In: Bogusz MJ, ed. Handbook of Analytical Separations. Elsevier: Amsterdam, 2000:197-223
18. Marquet P. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Ther Drug Monit 2002;24:255-76
19. NHS Purchasing and Supply Agency Centre for evidence based purchasing. Evidence Review: Healthcare Applications of Liquid Chromatography/Tandem Mass Spectrometry. 2009
20. Society of Forensic Toxicologists Inc. and Drug-Facilitated Sexual Assualt Committee. Recommended Maximum Detection Limits for Common DFSA Drugs and Metabolites in Urine Samples. 2005:1-4
21. Allen KR. Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine. Clin Toxicol (Phila) 2006;44:147-53
22. Fox EJ, Twigger S, Allen KR. Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: problems in routine practice. Ann Clin Biochem 2009;46:50-7
23. Sauvage FL, Gaulier JM, Lachatre G, Marquet P. Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clin Chem 2008;54:1519-27
24. Rivier L. Criteria for the identification of compounds by liquid chromatography-mass spectrometry and liquid chromatography-multiple mass spectrometry in forensic toxicology and doping analysis. Anal Chim Acta 2003;492:69-82
25. Maralikova B, Weinmann W. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. J Chromatogr B Anal Technol Biomed Life Sci 2004;811:21-30
26. Babiker E, Abdulkader A, Heyman A. Cross-reactivity of nefopam and its metabolites with benzodiazepine EMIT immunoassay. J Anal Toxicol 2008;32:790-2
27. Blank A, Hellstern V, Schuster D, et al. Efavirenz treatment and false-positive results in benzodiazepine screening tests. Clin Infect Dis 2009;48:1787-9
28. Camara PD, Audette L, Velletri K, Breitenbecher P, Rosner M, Griffiths WC. False-positive immunoassay results for urine benzodiazepine in patients receiving oxaprozin (Daypro). Clin Chem 1995;41:115-6
29. Crane T. Mefenamic acid prevents assessment of drug abuse with EMIT assays. Clin Chem 1993;39:549-9
30. Beckman Coulter Ireland Inc. SYNCHRON Systems Chemistry Information Sheet: Benzodiazepine, 2008